Results 221 to 230 of about 322,328 (395)

The Routine Determination of the Endogenous Thrombin Potential, First Results in Different Forms of Hyper- and Hypocoagulability

, 1997
Simone Wielders, Manjarí Mukherjee, Jan Michiels, Dirk T. S. Rijkers, Jean‐Pierre Cambus, Richard Knebel, Vijay V. Kakkar, H.C. Hemker, Suzette Beguı́n   +8 more
openalex   +2 more sources

Coronary arterial bypass surgery with beating heart in a patient with heparin-induced thrombocytopenia: Usage of thrombin inhibitor (Lepirudin; r-hirudin) [PDF]

, 2010
Bilgehan Erkut, Necip Becit, Serpil Diler, Münacettin Ceviz   +3 more
openalex   +1 more source

New Technologies Empower Hemophilic Arthropathy Treatment: Focusing on Regenerative Medicine, Molecular Targeting, and Gene Therapy

Medicine Bulletin, EarlyView.
ABSTRACT Hemophilic arthropathy (HA), a major complication of hemophilia, is a chronic osteoarthropathy driven by repeated joint bleeding. Although traditional therapies such as coagulation factor replacement, physical rehabilitation, and surgery can manage symptoms, they cannot fundamentally repair established joint damage or break the pathological ...
Lin Sun, Yingnan Wang, Leyuan Zhao, Liqiang Lu, Fushan Hou, Chuan Yin, Kun Zhang, Yongqiang Hao, Jingke Fu   +8 more
wiley   +1 more source

Identification of novel gene expression programs in thrombin-stimulated hepatic stellate cells. [PDF]

Res Pract Thromb Haemost
Mac NA, Prasad S, Capece GE, Martínez-Zamudio RI, McClenaghan C, Poole LG.   +5 more
europepmc   +1 more source

Determination of thrombin-antithrombin III complex(TAT) with an ELISA.

, 1989
Tsutomu Yamashita, Noriko Inoue, Seiji FUJII, Yoshiki Sato, Kunio Kobayashi, Koichi Mimura, Akira Matsuoka   +6 more
openalex   +2 more sources

Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

Cardiovascular Research, 2014
H. Spronk, A. de Jong, H. Crijns, U. Schotten, I. V. van Gelder, H. ten Cate   +5 more
semanticscholar   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Performance Verification of High Sensitivity Analyzer for TAT, PIC, TM, and t-PAIC. [PDF]

TH Open
Liu Y, Guo B, Chen G, Chen C, Meng Z, Xie Y, Fan Y, Ma R, Gao L.   +8 more
europepmc   +1 more source

Enhancing Selective Brain Cancer Therapy: Integrating Nanomedicine and Molecular Dynamics to Target the Cancerous Lipid Composition

Nano Select, EarlyView.
Improving selectivity within therapeutic design is critical to ensure targeted delivery to brain tumors. Targeting the cellular membrane composition distinctive of the blood–brain barrier and brain cancer cells is explored in this review. Nanomedicine can be utilized for precise tumor recognition, and detailed mechanistic interactions of therapeutics ...
Mahnoor Kadri, Dominique de Jong‐Hoogland, Martin B. Ulmschneider   +2 more
wiley   +1 more source

Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry. [PDF]

Res Pract Thromb Haemost
Tripodi A, Clerici M, Scalambrino E, Arcudi S, Gualtierotti R, Novembrino C, Peyvandi F.   +6 more
europepmc   +1 more source